BiotchPharma Rare diseases, by their nature, are rare and difficult to diagnose and identify the disease. Companies wishing to conduct clinical trials on orphan drugs are generally classified as II and III. They face problems in treating a sufficient number of patients for phase clinical studies.
BiotchPharma focuses on rare diseases for patients who need unmet therapy. Sustainable access to innovative and developing treatments is the right of every patient. That's why we strive to provide innovative Orphan Drugs in development to BiotchPharma patients and doctors
Biotchpharma on Turkey's pharmaceutical and genetic markets (especially oncology, hematology and rare diseases) serve. BiotchPharma consists of people with professional experience in different global companies in medical and genetics, sales and marketing, and reimbursement and registration (licensing) and post-trial access. With this knowledge and experience, we created BiotchPharma.
Turkey is a big market with a population of 80 million and growing field of health is very ope
info@biotchpharma.com
Rare Disease in the Pharmaceutical Sector and Rare Diseases -Start up drug -Early Access Program (Early Access) Country Manager in the field of Hematology Oncology and Psychiatry and Breast Cancer Tests
Start up and country management.
Entering new markets like oncology, hematology, orphan diseases and psychiatry. Developing KOLs and Advisory Board in those new markets.
Providing consultative, functional and operational support to for Expanded Access / Compassionate Use of investigational drugs.
Management of the relations with MoH (Ministry of Health), SGK (Social Security Institution) and TEB (Turkish Pharmasists Association which is the only wholesaler in NPI) on behalf of the Company
Specialties:
Head of Market Access
NPI (Named Patient Import)
Compassionate Use
Early Access Programmes
Sales
Marketing
Key Account Management
KOL management
Public affairs management
CRM
info@biotchpharma.com
Company Details
- Employees
- 10
- Founded
- -
- Address
- Turkiye, Istanbul 34485, Tr
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- biotchpharma.com
- Keywords
- Rare Diseases, Orphan Drugs, Early Access, Startup, Country Manager, Hematology, Oncology, Cardiology, Psychiatry, NPI (Named Patient Import), Compassionate Use, Early Access Programmes, Sales, Marketing, Key Account Management, KOL management, Public affairs management, Regional Manager, Sales Manager, Ultra Rare Diseases.
- HQ
- Turkiye, Istanbul
Biotchpharma Solutions Consulting Trading Company Questions
Biotchpharma Solutions Consulting Trading Company's website is biotchpharma.com
Biotchpharma Solutions Consulting Trading Company's LinkedIn profile is https://www.linkedin.com/company/biotchpharmaturkey
Biotchpharma Solutions Consulting Trading Company has
10 employees.
View email and phone details for 10
employees at Biotchpharma Solutions Consulting Trading Company.
Biotchpharma Solutions Consulting Trading Company's industry is
Pharmaceutical Manufacturing
Biotchpharma Solutions Consulting Trading Company's top competitors are
Siga/fsia,
Deva Holding A.ş.,
Zima,
Boston Scientific,
Icarus Pazarlama Ve Satış Danışmanlık Tic. Ltd. Şti.,
Zetua Türkiye,
Iqvia,
Tatton Pharm,
Branch Recruiter (Sold),
Biotechcro Medical Pharmaceutical Research Consultancy Trade Limited.
Biotchpharma Solutions Consulting Trading Company's categories are Pharmaceutical Manufacturing
Biotchpharma Solutions Consulting Trading Company's founding year is 2018
